Lupus

Glucocorticoids (GC) have been the mainstay of treatment in systemic lupus erythematosus (SLE) for nearly three quarters of a century. Through their genomic and non-genomic actions, GC induce a range…

Pregnancy in lupus patients is a complex situation, posing significant concerns for both patients and physicians due to the risk of adverse pregnancy outcomes. These outcomes can range from increased…

Systematic lupus erythematosus (SLE), a chronic autoimmune multi-system inflammatory condition, can present with various, sometimes severe, clinical manifestations, leading to high levels of…

Wednesday was Day One at EULAR 2024 in Vienna. While the day was a slow start, the poster halls and auditoriums quickly filled with thousands of rheumatologists, eager to reunite at this…

Large language models, such as ChatGPT, are advanced systems trained on vast amounts of text data, far exceeding what a human can read in a lifetime, to understand and generate human-like language.…

Inhibition of B cell activating factor (BAFF) and B cell depletion are the two most evaluated strategies over the last 15 years in the field of SLE therapeutics, with licensing of belimumab and off-…